Novel RNA Interference (RNAi)-Based Nanomedicines for Treating Viral Infections - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 234

75. Lemon, S. M., Walker, C., Alter, M. J. and Yi, M. (2007) Fields Virology
1, eds. Knipe, D. M. and Howley, P. M., Chapter 35 “Hepatitis C Virus”
(Lippincott Williams & Wilkins, Philadelphia) pp. 1253-1304.
76. Levine, B. L., Humeau, L. M., Boyer, J., MacGregor, R. R., Rebello, T., Lu,
X., Binder, G. K., Slepushkin, V., Lemiale, F., Mascola, J. R., Bushman, F.
D., Dropulic, B. and June, C. H. (2006). Gene transfer in humans using a
conditionally replicating lentiviral vector. Proc Natl Acad Sci U S A, 103,
pp. 17372-17377.
77. Li, B. J., Tang, Q., Cheng, D., Qin, C., Xie, F. Y., Wei, Q., Xu, J., Liu, Y., Zheng,
B. J., Woodle, M. C., Zhong, N. and Lu, P. Y. (2005). Using siRNA in
prophylactic and therapeutic regimens against SARS coronavirus in
Rhesus macaque. Nat Med, 11, pp. 944-951.
78. Li, M. J., Bauer, G., Michienzi, A., Yee, J. K., Lee, N. S., Kim, J., Li, S.,
Castanotto, D., Zaia, J. and Rossi, J. J. (2003). Inhibition of HIV-1 infection
by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol
Ther, 8, pp. 196-206.
79. Li, M. J., Kim, J., Li, S., Zaia, J., Yee, J. K., Anderson, J., Akkina, R. and
Rossi, J. J. (2005). Long-term inhibition of HIV-1 infection in primary
hematopoietic cells by lentiviral vector delivery of a triple combination
of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR
decoy. Mol Ther, 12, pp. 900-909.
80. Li, W.-X., Li, H., Lu, R., Li, F., Dus, M., Atkinson, P., Brydon, E. W. A.,
Johnson, K. L., Garcia-Sastre, A., Ball, L. A., Palese, P. and Ding, S.-W.
(2004). Interferon antagonist proteins of influenza and vaccinia
viruses are suppressors of RNA silencing. Proc Natl Acad Sci U S A, 101,
pp. 1350-1355.
81. Lindenbach, B. D., Thiel, H.-J. R. and Rice, C. M. (2007) Fields Virology 1,
eds. Knipe, D. M. and Howley, P. M., Chapter 33 “Flaviviridae: The Viruses
and Their Replication” (Lippincott Williams & Wilkins Philadelphia)
pp. 1101-1152.
82. Looker, K. J., Garnett, G. P. and Schmid, G. P. (2008). An estimate of
the global prevalence and incidence of herpes simplex virus type 2
infection. Bull World Health Organ, 86, pp. 805-812.
83. Lu, X., Humeau, L., Slepushkin, V., Binder, G., Yu, Q., Slepushkina, T., Chen,
Z., Merling, R., Davis, B., Chang, Y. N. and Dropulic, B. (2004). Safe two-
plasmid production for the first clinical lentivirus vector that achieves
>99% transduction in primary cells using a one-step protocol. J Gene
Med, 6, pp. 963-973.
84. Mackenzie, J. S., Gubler, D. J. and Petersen, L. R. (2004). Emerging
flaviviruses: the spread and resurgence of Japanese encephalitis, West
Nile and dengue viruses. Nature Medicine, 10, pp. S90-109.